New AI Model Enhances Protein-Ligand Binding Prediction

Shuai Li, Chuan-Xian Ren, Yuhao Li, Ziqi Huang, Yue Pan, Mingzhe Tang, Hong Yan· June 15, 2026 View original

Summary

Researchers introduce RicciBind, a geometric representation framework that improves protein-ligand binding affinity prediction, crucial for drug discovery. It integrates curvature-guided hierarchical structure learning with optimal transport-based alignment to model complex molecular interactions, leading to superior accuracy and interpretability.

This research introduces RicciBind, a novel geometric representation framework designed to significantly improve the prediction of protein-ligand binding affinity, a critical step in drug discovery. Existing machine learning methods often struggle to effectively model both localized geometric arrangements and broader, coordinated interactions between molecules. RicciBind addresses this by integrating two key components. First, it uses Ricci curvature to capture the tightness of local interactions within molecular structures, thereby creating curvature-aware hierarchical representations of atomic interactions. Second, it employs an optimal transport-based cluster matching mechanism to align protein and ligand clusters across different domains, ensuring globally consistent correspondences and revealing higher-order interaction patterns. By combining curvature-guided structural encoding with optimal transport-driven alignment, RicciBind effectively models complex interaction semantics. Extensive experiments demonstrate its superior predictive performance and generalization across various benchmarks and virtual screening tasks, also confirming the vital role of Ricci curvature in enhancing molecular interaction representations.

Why it matters

For pharmaceutical and biotechnology professionals, this advancement offers a more accurate and interpretable tool for predicting drug efficacy and identifying potential drug candidates earlier in the discovery process. It could accelerate drug development and reduce costs by improving the efficiency of virtual screening.

How to implement this in your domain

  1. 1Evaluate RicciBind or similar geometric deep learning models for your drug discovery pipelines.
  2. 2Explore incorporating curvature-based features into your molecular representation learning.
  3. 3Investigate optimal transport methods for aligning and comparing molecular structures.
  4. 4Pilot new AI-driven binding affinity prediction tools to enhance virtual screening campaigns.
  5. 5Collaborate with AI researchers to adapt these advanced geometric models to specific drug targets.

Who benefits

PharmaceuticalsBiotechnologyHealthcareChemical Engineering

Key takeaways

  • RicciBind improves protein-ligand binding affinity prediction using geometric AI.
  • It integrates curvature-guided structure learning and optimal transport alignment.
  • The model enhances both accuracy and interpretability in drug discovery.
  • This approach could accelerate virtual screening and drug candidate identification.

Original post by Shuai Li, Chuan-Xian Ren, Yuhao Li, Ziqi Huang, Yue Pan, Mingzhe Tang, Hong Yan

"arXiv:2606.14159v1 Announce Type: new Abstract: Protein-ligand binding affinity (PLA) prediction is critical in drug discovery. Despite the notable advancements in machine learning-based approaches, existing methods struggle to jointly characterize local geometric organization an…"

View on X

Originally posted by Shuai Li, Chuan-Xian Ren, Yuhao Li, Ziqi Huang, Yue Pan, Mingzhe Tang, Hong Yan on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses